Exploring the trimethylamine pathway in advanced chronic liver disease

Abstract The trimethylamine (TMA)-trimethylamine-N-oxide (TMAO) pathway, involving gut microbiota-derived metabolites, may play a role in advanced chronic liver disease (ACLD). This study assessed TMA and TMAO levels in ACLD patients and their associations with liver-related outcomes. Plasma samples...

Full description

Saved in:
Bibliographic Details
Main Authors: Jil T. Bürki, Jonas Schropp, Peter Neyer, Christian Steuer, Jaume Bosch, Annalisa Berzigotti, Susana G. Rodrigues
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:npj Gut and Liver
Online Access:https://doi.org/10.1038/s44355-025-00029-9
Tags: Add Tag
No Tags, Be the first to tag this record!